⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Pomerantz LLP Informs Shareholders of Class Action Filing Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
LEVI & KORSINSKY, LLP INVESTIGATING ALLEGED CLINICAL TRIAL DESIGN DEFICIENCIES AT VISTAGEN THERAPEUTICS -- CLASS ACTION FILED
prnewswire.com
VTGN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in Vistagen Lawsuit - VTGN
prnewswire.com
VTGN
Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference
businesswire.com
VTGN
Pomerantz LLP Informs Shareholders of Class Action Filing Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN
VTGN UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 Ready to Announce with Confidence?
newsfilecorp.com
VTGN
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTGN
globenewswire.com
VTGN